Bestevia Reb B Receives U.S. FDA GRAS No Objection Letter

Bestevia Reb B is found in trace amounts in the stevia leaf.
Bestevia Reb B is found in trace amounts in the stevia leaf.
Dasha Petrenko - stock.adobe.com

SweeGen’s Bestevia Rebaudioside B has received the Generally Recognized As Safe (GRAS) Letter of No Objection from the U.S. Food and Drug Administration (FDA).

Related: SweeGen Announces Commercialization of Bestevia Reb N

The GRAS status qualifies Reb B as one more high-purity, nature-based sweetener with a unique sensory profile to join Sweegen’s stevia portfolio, including Rebs D, E, I and M.

Casey McCormick, director of product development, said, “With a design-thinking approach for using consumer-preferred ingredients, coupled with Reb B’s characteristics and flexibility, such as good solubility and zero calories, we are very excited about collaborating with brands on functional beverages with unique flavors and nutritional ingredients."

Want to know everything going on in flavor & fragrance? Sign up for P&F+'s newsletter. You can also follow along on Instagram and LinkedIn

More in Regulatory & Research